Your browser doesn't support javascript.
loading
In silico screening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL.
Wang, Linxiao; An, Yufeng; Wei, Xiongpiao; Huang, Xiaoling; Tu, Yuanbiao; Qiao, Lukai; Zhu, Wufu.
Afiliación
  • Wang L; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China.
  • An Y; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China.
  • Wei X; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China.
  • Huang X; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China.
  • Tu Y; Cancer Research Center, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
  • Qiao L; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China.
  • Zhu W; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China.
J Biomol Struct Dyn ; : 1-13, 2023 Sep 10.
Article en En | MEDLINE | ID: mdl-37691424

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: J Biomol Struct Dyn Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: J Biomol Struct Dyn Año: 2023 Tipo del documento: Article País de afiliación: China